RUNX1 and chronic myelogenous leukemia, BCR-ABL1 positive: Other Evi1-reporter AML models by MOZ-TIF2 and TP+AE never generated Evi1-high fraction, suggesting the high affinity of Evi1 for stem cell disease such as CML.